BioScience Health Innovations (BHIC) Gross Profit (2023 - 2026)

BioScience Health Innovations (BHIC) has reported Gross Profit for 4 consecutive years, with $485596.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Gross Profit fell 45.81% year-over-year to $485596.0; the TTM figure through Mar 2026 stood at $2.8 million (up 43.64% YoY), while the FY2025 annual figure was $3.2 million, up 147.59% from the prior year.
• Gross Profit slipped to $485596.0 in Q1 2026 per BHIC's latest filing, from $571863.0 in the prior quarter.
• Across five years, Gross Profit topped out at $1.1 million in Q2 2025 and bottomed at $27591.0 in Q1 2023.
• Historically, Gross Profit has averaged $424585.2 across 4 years, with a median of $339009.0 in 2024.
• Annual changes were most pronounced in 2024 — Gross Profit surged 750.87% — and 2026, when it slumped 45.81%.
• BioScience Health Innovations' Gross Profit stood at $236511.0 in 2023, then soared by 43.34% to $339009.0 in 2024, then jumped by 68.69% to $571863.0 in 2025, then slipped by 15.09% to $485596.0 in 2026.
• Business Quant data shows BHIC's Gross Profit at $485596.0 in Q1 2026, $571863.0 in Q4 2025, and $698231.0 in Q3 2025.